ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2320

Superantigen Induces IL-17 Production From Extremely Polarized Th1 Clones

Kentaro Yomogida1, Yuan K. Chou1 and Cong-Qiu Chu2, 1Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, Portland, OR, 2Rheumatology, Oregon Health & Science Univ and Portland VA Medical Center, Portland, OR

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: interleukins (IL) and rheumatoid arthritis, pathogenesis, T cells

  • Tweet
  • Email
  • Print
Session Information

Title: T-cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Differentiation of naïve CD4+ T cells is considered to be an irreversible event and, in particular, the plasticity is thought to be completely lost in Th1 subset in vitro after multiple stimulations. Superantigens produced by different types of pathogens have been linked to autoimmune diseases. Superantigen-stimulation does not prime an adaptive immune response but causes a massive production of cytokines by CD4+ T cells. We hypothesized that superantigens are capable of stimulating Th1 cells to produce inflammatory cytokine, IL-17.  

Methods:

MOG35-55-specific and herpes simplex virus (HSV)-specific CD4+ T cell clones were established from PBMC of healthy individuals. These CD4+ T cell clones were stimulated by each antigen respectively under Th17 polarizing conditions (with addition of IL-1, IL-6, TGF-beta, anti-IL-12 and anti-IFN-ƒngamma) or cultured with bacterial superantigens, SEB or TSST-1. IL-17 and IFN-gamma production was determined by ELISA, double-color ELISPOT and intracellular cytokine staining.

Results:

Upon repeated Ag-specific stimulation, Th1 clones proliferated specifically to MOG35-55 and HSV respectively and produced IFN-gamma and IL-2, but did not produce IL-17. Various Th17-polarization conditions including co-stimulation with IL-1, TNF, IL-6, IL-23, TGF-beta in combination with anti-IL-12 and anti-IFN-gamma antibodies did not induce measurable IL-17 from these Th1 clones. However, superantigen-stimulation promoted both clones to produce IL-17 at a range of 0.5 – 1 ng/1×105 cells. Combination of SEB and TSST-1 showed additive effect on IL-17 production by Th1 clone cells where IL-17 level was greater than 2 ng/1×105 cells. Using double-color ELISPOT assay, we found 30% of IFN-gamma-producing cells were positive for IL-17, suggests that superantigens promoted IL-17 production from highly polarized Th1 cloned cells. Interestingly, IL-17 production by these Th1 clones was blocked by anti-HLA class II or anti-TCR alpha/beta chain antibodies.

Conclusion:

We have demonstrated that highly polarized Th1 clones can produce a significant amount of IL-17 in response to superantigen stimulation. Infections have been linked to exacerbation of autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. Stimulating Th1 cells to produce IL-17 by superantigens of infecting pathogens may be responsible.


Disclosure:

K. Yomogida,
None;

Y. K. Chou,
None;

C. Q. Chu,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/superantigen-induces-il-17-production-from-extremely-polarized-th1-clones/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology